I think this will settle at 10c in a few days and then it will be a slow grind back to 20c with the other clinical trial results. Interestingly, it has dropped more than the 1st failed US clinical trial but in a much better position, possibly as most of the SI are dumping those shares.
Ann: Update on US FDA De Novo Classification Request, page-64
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)